山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)17 Novel Dosage Forms And Drug Delivery Technologies 新型剂型与药物传递技术

Novel Dosage Forms And Drug Delivery Technologies
Novel Dosage Forms And Drug Delivery Technologies

Main Contents 1 Introduction 2. Topical Administration 3. Oral Administration 4. Vaginal Administration 5. Ophthalmics 6. Parenteral Administration 7. Peglated Dosage Forms 8.Fusion Protein 9.Implants 10.Other Novel Delivery Systems
2 Main Contents • 1. Introduction • 2.Topical Administration • 3.Oral Administration • 4.Vaginal Administration • 5.Ophthalmics • 6.Parenteral Administration • 7.Peglated Dosage Forms • 8.Fusion Protein • 9.Implants • 10.Other Novel Delivery Systems

Introduction This chapter discusses novel drug delivery systems that are modifications of those previously presented, are relatively new on the market or do not fit into categories in previous chapters They may be relatively new, use new or relativel new delivery systems, or use unique delivery systems or unique devices before, during, or after administration
3 Introduction • This chapter discusses novel drug delivery systems that are modifications of those previously presented, are relatively new on the market, or do not fit into categories in previous chapters. • They may be relatively new, use new or relativel new delivery systems, or use unique delivery systems or unique devices before, during, or after administration

Introduction Changes are coming about as new technologies are developed and reduce the limitations of existing therapies In some cases, the new drugs require new delivery systems because the traditional systems are inefficient or ineffective this may be true especially of some of the recombinant dna and gene therapies of the future
4 Introduction • Changes are coming about as new technologies are developed and reduce the limitations of existing therapies. • In some cases, the new drugs require new delivery systems because the traditional systems are inefficient or ineffective; this may be true especially of some of the recombinant DNA and gene therapies of the future

Benefits: A)improvement of patients compliance; B)improved outcomes c reduction of adverse effects; D)improvement of patients' acceptance of the treatment E)avoidance of costly interventions such as laboratory services; F) allowing patients to receive medication as outpatients Ga reduction in the overall use of medicinal resources 5
5 Benefits: • A) improvement of patients’ compliance; • B) improved outcomes; • C) reduction of adverse effects; • D) improvement of patients’ acceptance of the treatment; • E) avoidance of costly interventions such as laboratory services; • F) allowing patients to receive medication as outpatients • G) a reduction in the overall use of medicinal resources

Therapeutic benefits Optimization of the duration of action of the drug ecreasing dosage trequency Controlling the site of release Maintaining constant drug level
6 Therapeutic benefits • Optimization of the duration of action of the drug; • Decreasing dosage frequency, • Controlling the site of release, • Maintaining constant drug level

Safety benefits Reducing adverse affects Decreasing the number of concomitant medications patient must take Decreasing the need for interventions Reducing the number of emergency department visits
7 Safety benefits • Reducing adverse affects, • Decreasing the number of concomitant medications patient must take, • Decreasing the need for interventions • Reducing the number of emergency department visits

Economic benefits Simplifying administration regiments: Enhancing patients' compliance An overall reduction of health care costs Solute(Drug) Cell Membrane A头 Adhesion Fusion Endocytosis
8 Economic benefits • Simplifying administration regiments; • Enhancing patients’ compliance • An overall reduction of health care costs

Introduction The therapeutic efficacy of selected products can be enhanced and in some cases the toxicity can be decreased by incorporating nove drug delivery technologies
9 Introduction • The therapeutic efficacy of selected products can be enhanced and in some cases the toxicity can be decreased by incorporating novel drug delivery technologies

Introduction With these novel dosage forms and drug delivery technologies, some therapies may become very site specific; and more controlled drug delivery systems will be available in the very near future 10
10 Introduction • With these novel dosage forms and drug delivery technologies, some therapies may become very site specific; and more controlled drug delivery systems will be available in the very near future
按次数下载不扣除下载券;
注册用户24小时内重复下载只扣除一次;
顺序:VIP每日次数-->可用次数-->下载券;
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)06 Capsules 胶囊.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)16 Products of Biotechnology 生物技术(生物工程)产品.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)10 Transdermal Drug Delivery Systems 经皮给药系统.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)07 Tablets 药片、片剂.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)02 New Drug Development and Approval Process 新药开发和批准流程.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)14 Parenterals 肠外注射.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)13 Disperse Systems(分散体系).ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)12 Solutions.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)11 Suppositories and Inserts 栓剂.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)09 Ointments, Creams and Gels 软膏、面霜和凝胶.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)04 Dosage Form Design:Biopharmaceutic and Pharmacokinetic Considerations.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)08 MODIFIED-RELEASE DOSAGE FORMS AND DRUG DELEVERY SYSTEMS.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)03 Dosage Form Design:Pharmaceutic and Formulation Considerations.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)05 粉末和颗粒 Powders and Granules.ppt
- 山东大学:《药剂学 Pharmaceutics》课程教学资源(PPT课件讲稿,双语)01 Introduction to Drugs and Pharmacy 药物与药学导论.ppt
- 山东大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)Chapter 03 外周神经系统药物 Peripheral nervous system drugs.ppt
- 山东大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)Chapter 01 Introduction(主讲:马淑涛).ppt
- 山东大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)Chapter 12 维生素 Vitamins.ppt
- 山东大学:《药物化学 Medicinal Chemistry》课程教学资源(PPT课件讲稿)Chapter 13 New methods and techniques.ppt
- 复旦大学:《生物药剂学 Biopharmacy or Biopharmaceutics》教学课件_第六章 药物排泄 drug excretion 第一节 药物的肾排泄 第二节 药物的胆汁排泄 第三节 药物的其他排泄途径.pdf
- 复旦大学:《临床药物治疗学 Clinical Pharmacotherapeutics》课程教学资源(教学大纲)Clinical Pharmacotherapeutics I.pdf
- 复旦大学:《临床药物治疗学 Clinical Pharmacotherapeutics》课程教学资源(教学大纲)Clinical Pharmacotherapeutics II.pdf
- 《医学与哲学》:论不合理用药及其表现、判断和处理(复旦大学:叶晓芬、蔡映云、吕迁洲).pdf
- 《临床药物治疗学 Clinical Pharmacotherapeutics》教学论文:以1例合并多种基础疾病的膜性肾病药物治疗为例分析药物治疗矛盾的处理.pdf
- 《临床药物治疗学 Clinical Pharmacotherapeutics》教学论文:临床药师对高血压患者的药学服务及其效果(复旦大学:李 静、吕迁洲).pdf
- 《中国临床药学杂志》:临床药师参与1例门静脉炎并发药物热的病例分析(复旦大学:张晓丹、王斌).pdf
- 《上海医药》:临床药师参与治疗1例马尔尼菲青霉菌肺部感染.pdf
- 《临床药物治疗学 Clinical Pharmacotherapeutics》教学论文:中美临床药学发展(复旦大学:马国、相小强、蔡卫民、侯爱君).pdf
- 《中国临床药学杂志》:对1例紫癜性肾炎合并糖尿病患者的药学监护.pdf
- 《中国临床药学杂志》:标准化病人在临床药学教育中的应用(复旦大学:刘晓芹、相小强 等).pdf
- 《临床药物治疗学 Clinical Pharmacotherapeutics》阅读资料:Latest Developments in Neuroscience Drug Therapy(melody).pdf
- 《临床药物治疗学 Clinical Pharmacotherapeutics》阅读资料:Pharmacotherapy of Neuroscience(Melody).pdf
- 《临床药物治疗学 Clinical Pharmacotherapeutics》阅读资料:Pharmacotherapy of Special Populations(Melody).pdf
- 《临床药物治疗学 Clinical Pharmacotherapeutics》阅读资料:药物治疗的临床思维.pdf
- 复旦大学附属华山医院:《临床药物治疗学 Clinical Pharmacotherapeutics》讲稿_头痛(马春来).pdf
- 复旦大学附属华山医院:《临床药物治疗学 Clinical Pharmacotherapeutics》讲稿_急性缺血性脑卒中的治疗(马春来).pdf
- 国家基本公共卫生服务项目——国家基层高血压防治管理指南(2017).pdf
- 《中国医学前沿杂志(电子版)》:中国循证指南共识——高血压合理用药指南(第2版).pdf
- 《临床药物治疗学 Clinical Pharmacotherapeutics》参考资料:抗菌药物临床应用指导原则(2015年版).pdf
- 复旦大学:《临床药物治疗学 Clinical Pharmacotherapeutics》课程教学资源(安全讨论)胃癌辅助化疗讨论.pdf